Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Mikaeloff Y, Caridade G, Suissa S, Tardieu M.

Neurology. 2009 Mar 10;72(10):873-80. doi: 10.1212/01.wnl.0000335762.42177.07. Epub 2008 Oct 8.

PMID:
18843097
2.

Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.

Mikaeloff Y, Caridade G, Assi S, Tardieu M, Suissa S; KIDSEP study group of the French Neuropaediatric Society.

Brain. 2007 Apr;130(Pt 4):1105-10. Epub 2007 Feb 1.

PMID:
17276994
3.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
4.

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.

Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M.

Arch Pediatr Adolesc Med. 2007 Dec;161(12):1176-82.

PMID:
18056563
5.

[The first episode of central nervous system demyelinization and hepatitis B virus vaccination].

Touzé E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alpérovitch A.

Rev Neurol (Paris). 2000 Mar;156(3):242-6. French.

PMID:
10740095
6.

Vaccinations and risk of central nervous system demyelinating diseases in adults.

DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT; Vaccine Safety Datalink Research Group, National Immunization Program, Centers for Disease Control and Prevention.

Arch Neurol. 2003 Apr;60(4):504-9.

PMID:
12707063
7.

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Lièvre M; Members of Epidemiology Working Group of French Pharmacovigilance Commission, Costagliola D, Evans S, Fourrier A, Imbs JL, Levy-Bruhl D, Merle L, Micallef J, Oger E.

Neurology. 2009 Oct 27;73(17):1426-7. doi: 10.1212/WNL.0b013e3181bd1f7e. No abstract available.

PMID:
19858469
8.

Hepatitis B vaccine and risk of multiple sclerosis.

DeStefano F, Verstraeten T, Chen RT.

Expert Rev Vaccines. 2002 Dec;1(4):461-6. Review.

PMID:
12901584
9.

Hepatitis B vaccination and the risk of multiple sclerosis.

Ascherio A, Zhang SM, Hernán MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM.

N Engl J Med. 2001 Feb 1;344(5):327-32.

10.

Vaccination history and risk of childhood leukaemia.

Ma X, Does MB, Metayer C, Russo C, Wong A, Buffler PA.

Int J Epidemiol. 2005 Oct;34(5):1100-9. Epub 2005 Jun 10.

PMID:
15951359
11.

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.

Touzé E, Fourrier A, Rue-Fenouche C, Rondé-Oustau V, Jeantaud I, Bégaud B, Alpérovitch A.

Neuroepidemiology. 2002 Jul-Aug;21(4):180-6.

PMID:
12065880
12.

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Braillon A, Dubois G.

Neurology. 2009 Jun 9;72(23):2053. doi: 10.1212/01.wnl.0000349654.35791.27. No abstract available.

PMID:
19506233
13.

Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis.

Mikaeloff Y, Caridade G, Suissa S, Tardieu M; KIDSEP Study Group.

Am J Epidemiol. 2009 May 15;169(10):1260-6. doi: 10.1093/aje/kwp039. Epub 2009 Mar 27.

PMID:
19329530
14.

Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.

Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P, Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):736-45.

PMID:
17192842
15.

[A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination?].

Cabrera-Gómez JA, Echazabal-Santana N, García González L, Ramos Cedeño AM, Rodríguez Roque MO, López Hernández O, Cabrera Núñez JA, González De La Nuez J, Téllez L.

Rev Neurol. 2002 Feb 16-28;34(4):358-63. Spanish.

16.

Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

Hocine MN, Farrington CP, Touzé E, Whitaker HJ, Fourrier A, Moreau T, Tubert-Bitter P.

Vaccine. 2007 Aug 1;25(31):5938-43. Epub 2007 Jun 8.

PMID:
17597263
17.

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.

Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S; Vaccines in Multiple Sclerosis Study Group.

N Engl J Med. 2001 Feb 1;344(5):319-26.

18.

Hepatitis B vaccine and demyelination (cont'd).

[No authors listed]

Prescrire Int. 1999 Apr;8(40):52.

PMID:
10848063
19.

Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.

Payne DC, Rose CE Jr, Kerrison J, Aranas A, Duderstadt S, McNeil MM.

Arch Neurol. 2006 Jun;63(6):871-5.

PMID:
16769869
20.

Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.

Tosti ME, Traversa G, Bianco E, Mele A.

Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):388-91.

PMID:
10470598

Supplemental Content

Support Center